We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Key Highlights Osprey Medical has been selected as a Supplier Horizon Award recipient by Premier Inc. Osprey is one of nine suppliers to win the prestigious award, and is the only cardiovascular...
Key Highlights Osprey Medical has received European CE Marking approval for the 2nd generation DyeVert Power XT device Approval of DyeVert Power XT (for automatic injection) means the full...
GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia...
Key highlights US$7m private placement to Allan Gray at an issue price of US$0.11 per CDI 1 for 5 non-renounceable entitlement offer to be offered to eligible holders at the same...
Osprey Medical (ASX:OSP) today announced a multi-center observational study for the DyeVert Plus™ System will feature at the Society for Cardiovascular Angiography and Interventions (SCAI...
Highlights Over-subscribed Placement with commitments received from sophisticated and professional investors to raise approximately A$22.2 million at an issue price of A$0.40 per CDI...
Highlights Commitments received from an oversubscribed private placement to sophisticated and institutional investors raising approximately A$28 Million at an issue price of A$0.28...
http://www.fool.com.au/2015/10/19/4-asx-stocks-sinking-today/?utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
Osprey Medical Inc. (ASX: OSP) has today announced it has received commitments for a heavily oversubscribed private placement of 30,800,000 CHESS Depositary Interests (CDIs...
Osprey Medical Inc. (ASX: OSP) today announced that Dr. Roxana Mehran will be the Principal Investigator (PI) of the AVERT Trial. This trial will evaluate the Company’s AVERT™ System for a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | -0.52 | -72.2222222222 | 0.72 | 0.745 | 0.2 | 36190 | 0.41338518 | DE |
260 | 0.161 | 412.820512821 | 0.039 | 1.055 | 0.008 | 5327335 | 0.0344737 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions